Core Viewpoint - Altimmune's experimental drug has shown positive results in improving liver scarring and overall liver health after 48 weeks of treatment in a mid-stage study focused on patients with serious fatty liver disease [1] Group 1 - The drug demonstrated significant improvement in liver health indicators after a 48-week treatment period [1] - The study involved patients suffering from a serious condition known as fatty liver disease [1]